Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K
Chemical Synapses01:26

Chemical Synapses

10.6K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.6K
Chemical Synapses01:26

Chemical Synapses

3.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
3.8K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.5K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

1.2K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Cognitive synaptopathy: synaptic and dendritic spine dysfunction in age-related cognitive disorders.

Frontiers in aging neuroscience·2026
Same author

Machine Learning in Single-Molecule Tracking Analysis of Superresolution Optical Microscopy Data.

Cells·2026
Same author

Synapse-associated neuropathological markers in Alzheimer disease.

Brain : a journal of neurology·2026
Same author

Quantitative evaluation of methods to analyze motion changes in single-particle experiments.

Nature communications·2025
Same author

Concurrent diffusion of nicotinic acetylcholine receptors and fluorescent cholesterol disclosed by two-colour sub-millisecond MINFLUX-based single-molecule tracking.

Nature communications·2025
Same author

Nicotinic acetylcholine receptors in the brain.

Handbook of clinical neurology·2025

Related Experiment Video

Updated: Nov 18, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K

Cholesterol in myasthenia gravis.

Mariela L Paz1, Francisco J Barrantes2

  • 1Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Inmunología, Buenos Aires, Argentina; CONICET, Universidad de Buenos Aires, Instituto de Estudios de la Inmunidad Humoral "Prof. Dr. Ricardo A. Margni" (IDEHU), Buenos Aires, Argentina.

Archives of Biochemistry and Biophysics
|February 6, 2021
PubMed
Summary

Myasthenia gravis disrupts neuromuscular junctions, affecting skeletal muscle function. This review explores cholesterol

Keywords:
Autoimmune diseasesCholesterolImmune responseMembrane homeostasisMyasthenia gravisNicotinic receptor

More Related Videos

The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
12:18

The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy

Published on: December 26, 2014

22.2K
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

6.4K

Related Experiment Videos

Last Updated: Nov 18, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K
The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
12:18

The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy

Published on: December 26, 2014

22.2K
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

6.4K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • The cholinergic neuromuscular junction facilitates skeletal muscle signaling via acetylcholine.
  • Myasthenia gravis (MG) involves autoimmune attacks on nicotinic acetylcholine receptors.
  • Cholesterol is crucial for postsynaptic membrane function and nicotinic receptor modulation.

Purpose of the Study:

  • To review myasthenia gravis pathophysiology and postsynaptic membrane dysfunction.
  • To examine cholesterol metabolism dysregulation in MG myocytes due to antibody-receptor interactions.
  • To discuss statin effects on skeletal muscle and implications for MG patients.

Main Methods:

  • Literature review of myasthenia gravis pathophysiology.
  • Analysis of cholesterol's role in postsynaptic membranes.
  • Examination of statin effects on skeletal muscle.

Main Results:

  • Antibody-receptor interactions in MG dysregulate cholesterol metabolism in myocytes.
  • Cholesterol levels are significantly altered in the postsynaptic membrane in MG.
  • Statins, cholesterol-lowering drugs, have known effects on skeletal muscle.

Conclusions:

  • Myasthenia gravis profoundly impacts postsynaptic membrane cholesterol.
  • Understanding cholesterol dysregulation is key to MG pathophysiology.
  • Further research is needed on statin implications for MG patients.